| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Dec―11 |
Japan-Korea collaboration on biophysical techniques for drug discovery in infectious diseases: Toward future pandemic preparedness |
Katsumi Maenaka |
| 2 |
[GO] |
2024―Jan―23 |
The Asian Biophysics Association: Reborn from the COVID-19 pandemic |
Shang-Te Danny Hsu |
| 3 |
[GO] |
2023―Sep―20 |
<i>E. coli</i> production of a multi-disulfide bonded SARS-CoV-2 Omicron BA.5 RBD exhibiting native-like biochemical and biophysical properties |
Rawiwan Wongnak, Subbaian Brindha, Takahiro Yoshizue, Sawaros Onchaiya, Kenji Mizutani, Yutaka Kuroda |
| 4 |
[GO] |
2021―Oct―04 |
Current Status of Structure-based Drug Repurposing against COVID-19 by Targeting SARS-CoV-2 Proteins |
Atsushi Hijikata, Clara Shionyu, Setsu Nakae, Masafumi Shionyu, Motonori Ota, Shigehiko Kanaya, Tsuyoshi Shirai |
| 5 |
[GO] |
2021―Aug―20 |
Microsecond molecular dynamics suggest that a non-synonymous mutation, frequently observed in patients with mild symptoms in Tokyo, alters dynamics of the SARS-CoV-2 main protease |
Daisuke Kuroda, Kouhei Tsumoto |
| 6 |
[GO] |
2021―Feb―09 |
Antigen tests for COVID-19 |
Yuta Kyosei, Sou Yamura, Mayuri Namba, Teruki Yoshimura, Satoshi Watabe, Etsuro Ito |
